Skip to content
★ Sign in to follow
DH

Daniel H. Petree

Board Director
Director
Sutro Biopharma, Inc.Apollo Endosurgery, Inc.
Total declarations
20
Companies
2
▲ Purchases (3 ops.)
€23k
▼ Sales (1 ops.)
€1,581

Latest filing published 29 Jun 2023 for Sutro Biopharma, INC..

Filing timeline

BuySale
Daniel H. Petree

Insider track record

Disclosed buys
3
Disclosed sells
1
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Daniel H. Petree: trading record in brief

Daniel H. Petree (board member) discloses dealings in 2 companies, chiefly Sutro Biopharma, Inc. and Apollo Endosurgery, Inc. Over a trading history stretching from 10 February 2014 to 27 June 2023, the count stands at 20 filings.

On the open market, the record shows 3 purchases worth €23k and 1 sale worth €1,581. The net balance comes to €21k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 14 option exercises.

The median purchase comes to €6,604.

The newest entry dates from 29 June 2023: a transaction, in Sutro Biopharma, Inc. The last insider purchase was made public on 12 December 2014, 4,350 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Daniel H. Petree

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total

20 of 20 declarations